Unresectable Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-13
Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors [Phase 1]
A Phase 1 trial by the National Cancer Institute is evaluating the combination of Peposertib (M3814) and Tuvusertib (M1774) in patients with…